Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_assertion type Assertion NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_head.
- NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_assertion wasGeneratedBy ECO_0000203 NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_provenance.
- NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_assertion wasDerivedFrom befree-2016 NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_provenance.
- NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_assertion SIO_000772 22117530 NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_provenance.
- NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_assertion evidence source_evidence_literature NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_provenance.
- NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_provenance.